[Federal Register Volume 60, Number 144 (Thursday, July 27, 1995)]
[Notices]
[Page 38634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-18326]




  Federal Register  / Vol. 60, No. 144 / Thursday, July 27, 1995 / 
Notices  

[[Page 38634]]


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Statement of Organization, Functions, and Delegations of 
Authority

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

     Notice is hereby given that I have delegated to the Chair and 
Members of the Departmental Appeals Board authority to review 
administrative civil money penalty decisions pursuant to part 17 (21 
CFR part 17). This authority was delegated to me by the Secretary of 
Health and Human Services under: The Federal Food, Drug, and Cosmetic 
Act, 21 CFR 5.10(a)(1); section 351 of the Public Health Service Act 
(42 U.S.C. section 262) concerning biologic recall orders, 21 CFR 
5.10(a)(5); the National Childhood Vaccine Injury Act of 1986 (42 
U.S.C. section 300aa-28) concerning authority to impose administrative 
civil money penalties, 21 CFR 5.10(a)(35); and the Mammography Quality 
Standards Act of 1992 (42 U.S.C. section 263b(h)(2)), 21 CFR 
5.10(a)(36). This authority concerns making final determinations with 
respect to the imposition of administrative civil monetary penalties on 
review of, or by declining to review, initial decisions and decisions 
granting summary decisions of Administrative Law Judges, as set forth 
in 21 CFR part 17.
    This delegation becomes effective August 28, 1995.

    Dated: July 20, 1995.
David A. Kessler,
Commissioner of Food and Drugs.
[FR Doc. 95-18326 Filed 7-26-95; 8:45 am]
BILLING CODE 4160-01-F